Home / Brand archive
21 reported ongoing
23 records in this archive. Latest source date Jun 29, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class IIReported ongoing
Distribution: USA Nationwide
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class IIReported ongoing
Distribution: USA Nationwide
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class IIReported ongoing
Distribution: USA Nationwide
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Class IIReported ongoing
Distribution: Nationwide in the USA
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Class IIReported ongoing
Distribution: Nationwide in the USA
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Class IIReported ongoing
Distribution: Nationwide in the USA
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Class IIReported ongoing
Distribution: Nationwide in the USA
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Class IIIReported ongoing
Distribution: U.S.A. Nationwide
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Class IIIReported ongoing
Distribution: U.S.A. Nationwide
Presence of Particulate Matter.
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed PH Specifications
Class IIIReported ongoing
Distribution: Nationwide in the USA
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Class IIReported ongoing
Distribution: Nationwide in the US
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Class IIReported ongoing
Distribution: Nationwide in the US
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Class IIReported ongoing
Distribution: Nationwide in the US
Failed stability specifications: Out of specification for hardness test
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed stability specifications: Out of specification for hardness test
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Class IIIReported ongoing
Distribution: U.S. Nationwide.
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
Class IIReported ongoing
Distribution: Distributed Nationwide in the USA
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Class IIReported ongoing
Distribution: USA nationwide.
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 23 records, including 21 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.